Position in ROIV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$413,156,307
+$131,101,695 QoQ
Shares Held
11,674,380
+14.7% QoQ
Ownership
1.62%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#11
of 494 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,415,676 across 520 Biotechnology names. ROIV ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ROIV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $413,156,307 | 11,674,380 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $282,054,612 | 10,182,477 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $176,931,947 | 8,153,546 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $124,105,246 | 8,202,594 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $87,346,996 | 7,750,399 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $80,390,914 | 7,967,385 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $91,940,760 | 7,771,831 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $89,378,499 | 7,745,104 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $66,431,381 | 6,284,899 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $63,733,756 | 6,046,846 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $62,040,988 | 5,524,576 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $60,948,342 | 5,218,180 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $27,619,250 | 2,740,005 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $11,966,249 | 1,621,443 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,190,287 | 1,525,693 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,649,956 | 1,444,086 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,634,801 | 1,384,472 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,373,484 | 1,290,179 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,694,180 | 1,160,137 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||